Province of South Holland awards a subsidy of €200,000 to a joint project between SeraNovo and PercurosTuesday, January 30, 2018
Over time this will create a new wave of medications in fields including Cancer, HIV and Arthritis. The test of Percuros will be safer and cheaper than commercially available tests, while granting SeraNovo one of the best testing platforms for simulating the human gastro-intestinal tract to optimise their technology and prove its efficacy. Combining these two innovations will allow SeraNovo to bring more cures to patients and come one step closer to solving a big problem the pharmaceutical industry has with declining solubility of newly developed medicines.
Pharming announces abstracts presented at The Western Society of Allergy, Asthma & Immunology (WSAAI) conference
ISA Pharmaceuticals Announces Start of Phase 2 Combination Trial of ISA101b and Regeneron’s Cemiplimab in Oropharyngeal Cancer
Mymetics Virosomes Successful in Allergy Proof-of-Concept Study